General Information
Revision date
2006-12-18
Product name
Lipase Calibrator
1.2.1 Relevant identified uses
For the calibration of assays using BIOLABO LIPASE Reagent REF 99881; REF 99891 Company/Undertaking identification and emergency phone number
Manufacturer Name
F-02160 MAIZY (FRANCE) ORFILA
Icons in SDS
Company Information
company name
n i c h o l l f u e l o i l s l i m i t e d
Section 2
Precautionary statements
May be irritating to eyes, respiratory system and skin. Avoid contact with eyes and skin. Do not ingest or inhale. The bovine serum albumin (BSA) in this product is of US origin. The BSA was obtained from a supplier who holds a Certificate of Origin, Certificate of Analysis, and/or an EDQM Certificate of Suitability documenting the evaluation of reduction of TSE (Transmissible Spongiform Encephalopathy) risk. The lipase in this preparation is derived from human pancreas. The donors have been tested by FDA-approved methods and found to be negative for the presence of hepatitis B virus surface antigen (HBsAg), human immunodeficiency virus (HIV) 1 & 2 and hepatitis C virus (HCV). However, because no test method can provide complete assurance that infectious agents are absent, this product should be handled as a potentially biohazardous material in accordance with universal/standard precautions. Preparation appearance: white powder.
Principle Routes of Exposure
Typical occupational exposure routes are inhalation, eye and skin contact.
Potential health effects
Inhalation Inhalation may be irritating to the nasal passages and throat. Eye Eye exposure may cause irritation, redness and watering. Skin Skin contact may cause irritation, dryness and redness. Ingestion Ingestion may produce digestive irritation or discomfort.
Potential chronic health
Chronic effects from repeated or long-term occupational exposure to this preparation are unknown. Target Organs None expected. Regulatory Status: This preparation is classified as hazardous under U.S. OSHA 29 CFR 1910.1200; E.C. Directive 1999/45/EC; Canadian R.S. 1985, c. H-3; U.K. CHIPS 2002 No. 1689; and/or U.N. GHS ST/SG/AC 10/30. Refer to Sec. 15, Regulatory Information, for details regarding hazard classification. None of the components present in this preparation at concentrations equal to or greater than 0.1% are listed by IARC, NTP, OSHA or ACGIH as a carcinogen. Measures Symptoms: Not available. First aid: If overexposed, remove affected clothing and shower off remaining material. Move to a clean wel ventilated area. Excessive amount of material comes in contact with the eyes, flush wel with water. Ensure adequate flushing of the eye by separating the eyelids with the fingers. If breathing becomes difficult, a rash develops, or other allergic symptoms present, seek medical attention immediately.
